"Mr Brennan, who assumed the role of CEO in early 2015, believes the business could be a success story like Cochlear. Before taking on the top job he had tried to convince his previous employer Smith & Nephew to buy PolyNovo but when they said it was too early and speculative, he "put his money where his mouth is" and moved companies."
ASX200 rebalance, page-22
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.07 |
Change
0.030(1.47%) |
Mkt cap ! $1.429B | |||
| Open | High | Low | Value | Volume |
| $2.11 | $2.12 | $2.05 | $2.783M | 1.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 19976 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.07 | 9633 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |